30 / 64
90
A. M. Herrera G. et al.
44.- SCHUH S, DICK P T, STEPHENS D, HARTLEY M,
KHAIKIN S, RODRIGUES L, et al. High-dose inhaled
fluticasone does not replace oral prednisolone in chil-
dren with mild to moderate acute asthma. Pediatrics
2006; 118: 644-50.
45.- ROWE B H, BRETZLAFF J A, BOURDON C, BOTA
G W, CAMARGO C A Jr. Intravenous magnesium
sulfate treatment for acute asthma in the emergency
department: a systematic review of the literature. Ann
Emerg Med 2000; 36: 181-90.
46.- CHEUK D K, CHAU T C, LEE S L. A meta-analysis
on intravenous magnesium sulphate for treating acute
asthma. Arch Dis Child 2005; 90: 74-7.
47.- MOHAMMED S, GOODACRE S. Intravenous and
nebulized magnesium sulphate for acute asthma: syste-
matic review and meta-analysis. Emerg Med J 2007; 24:
823-30.
48.- KEMP S F, LOCKEY R F, SIMONS F E. World Aller-
gy Organization ad hoc Committee on Epinephrine
in anaphylaxis Epinephrine: the drug of choice for
anaphylaxis. A statement of the World Allergy Organi-
zation. Allergy 2008; 63: 1061-70.
49.- WALLIS G, PRASADA. Who needs chest physiothera-
py? Moving from anecdote to evidence. Arch Dis Child
1999; 80: 393-7.
50.- WOOD P R, HILL V L, BURKS M L, PETERS J I,
SINGH H, KANNAN T R, et al.
Mycoplasm pneumo-
niae
in children with acute and refractory asthma. Ann
Allergy Asthma Immunol 2013; 110: 328-34.
51.- RODRIGO G, RODRIGO C. ANew index for early pre-
diction of hospitalization in patients with acute asthma.
Am J Emerg Med 1997; 15: 8-13.
Correspondencia a:
Dra. Ana María Herrera G.
Clínica Santa María
Bellavista 0415. Santiago, Chile.
Email:
amherrerag@yahoo.comRev Chil Enf Respir 2014; 30: 81-90